Microcoat now offering Assay Development and Sample Measurement on MSD® Platform

Microcoat expands its technological portfolio by Meso Scale Discovery´s Electrochemiluminescence (MSD-ECL) platform. Based on non-radioactive electrochemiluminescent labels for ultra-sensitive detection, MSD yields higher sensitivity and broader dynamic range compared to ELISA technology. Microcoat offers development of assays from the scratch as well as transfer of classical ELISA formats in addition to method comparison, validation and sample measurement. Customers profit from our year-long experience in custom-fit optimization and manufacturing of antibody conjugates including MSD´s SULFO-Tag®.
MORE NEWS
- 29Jul
Microcoat at Pharmalab 2022
Read More → - 22Jul
EU innovation radar launches SciFiMed project- MicroCoat proud to be part of the project!
Read More → - 05Mai
Microcoat announces the 6th Monocyte-Activation Test Proficiency Test Program
Read More → - 14Apr
30 Years Microcoat
Read More → - 10Mrz
Donation handover Ahrtal
Read More → - 21Okt
We are back!
Read More → - 07Okt
Microcoat at BayernsBest50
Read More → - 07Okt
Job- und Ausbildungsmesse 14.10.2021 11:00 Uhr bis 21:00 Uhr in der Tiefenstollenhalle Peißenberg
Read More → - 29Sep
Job- und Ausbildungsmesse 05.10.2021 11:30 Uhr bis 21:00 Uhr in der Stadthalle Penzberg
Read More → - 06Sep
New trainees in September 2021
Read More →